Sanofi builds in OTCs with Chattem; drops two Ph III drugs
French drugmaker Sanofi Aventis will pay $1.9bn (€1.3bn) for OTC firm Chattem, according to a statement released yesterday.
Archives for December 22, 2009
XenoTech rolls out CryostaX offering for drug developers
US CRO and discovery technology supplier XenoTech has launched CryostaX, which it claims is the largest single-freeze pool of human hepatocytes available to drug developers.
Delays, takeover bids and Puerto Rico hurt 09, but Patheon up about 2010
Patheon says a slowdown in “outsourcing decision making,” manufacturing problems in Puerto Rico and cost related to JLL’s takeover bid hurt it in fiscal 09.
Appointments at Merck & Co, MediGene and Medivation, as well as departures at Bristol-Myers Squibb and KV Pharmaceutical – People on the move
In-Pharmatechnologist presents its latest round up of movements in the pharma sector, including appointments at Merck & Co, MediGene and Medivation, as well as departures at Bristol-Myers Squibb and KV Pharmaceutical.
New discovery services firm Biocius begins operations
US genomic analysis group BioTrove has completed the spin out of Biocius Life Sciences, a new contract drug discovery company.